3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
4
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
7
Colorectal Neoplasms
5
Head and Neck Neoplasms
3
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Salivary Gland Neoplasms
2
Rectal Neoplasms
2
Radiation Injuries
2
Neoplasm, Residual
2
Esthesioneuroblastoma, Olfactory
2
Depression
2
Colonic Neoplasms
2
Carcinoma, Intraductal, Noninfiltrating
2
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Skin Abnormalities
1
Sarcopenia
1
Sarcoglycanopathies
1
Resectable Pancreatic Cancer
1
Recurrence
1
Postoperative Complications
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Pain
1
Ovarian Neoplasms
1
Ototoxicity
1
Neoplastic Cells, Circulating
1
Malnutrition
1
Lymphatic Metastasis
1
Liver Neoplasms
1
Interventions
Surveys and Questionnaires
9
Cystectomy
6
Blood Specimen Collection
5
Neoadjuvant Therapy
4
Cystoscopy
4
Drug Therapy
3
avelumab
2
Urination
2
Urinary Diversion
2
Surgical Procedures, Operative
2
Radiotherapy
2
Pioglitazone
2
Microarray Analysis
2
Methods
2
Magnetic Resonance Spectroscopy
2
Interviews as Topic
2
Immunohistochemistry
2
Defecation
2
Biopsy
2
5-aminolevulinic acid hexyl ester
2
trastuzumab deruxtecan
1
sargramostim
1
pembrolizumab
1
erdafitinib
1
enfortumab vedotin
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Watchful Waiting
1
Urinary Sediment Analysis
1
Therapeutics
1
Specimen Handling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Urinary Bladder Neoplasms
×
Chemotherapy, Adjuvant
×
Clear all
NCT03789682
2025-04-16
CD155 in Bladder Cancer
Fudan University
Completed
151 enrolled